Search Medical Condition
Please enter condition
Please choose location from dropdown

Johnston, Rhode Island Clinical Trials

A listing of Johnston, Rhode Island clinical trials actively recruiting patient volunteers.

RESULTS

Found (294) clinical trials

The VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira and BI 695501 in Patients With Plaque Psoriasis.

The primary objective of the trial is to assess the PK similarity between patients receiving Humira continuously vs those who alternate between BI 695501 and Humira, in patients with moderate-to-severe chronic plaque psoriasis. The secondary objectives of this trial are to descriptively compare the safety, immunogenicity and efficacy profiles between ...

Phase

0.36 miles

Learn More »

Study of Acute Uncomplicated Seasonal Influenza A in Adult Subjects

The primary objective of the study is to evaluate the time to resolution of influenza symptoms in adults with acute uncomplicated seasonal influenza A following administration of VX-787, with and without concomitant oseltamivir.

Phase

0.36 miles

Learn More »

If you have been diagnosed with acne, and are 12 years old or older, you may qualify to participate in a research study to evaluate an investigational medication for acne. Study participants will receive: Study Medications Study related testing Physical exams at no cost Compensation for time and travel For ...

Phase N/A

0.36 miles

Learn More »

If you have been diagnosed with chronic plaque-type psoriasis and are between18 and 70 years old, you may qualify to participate in a research study to evaluate and investigational medication for the treatment of plaque psoriasis. Qualified Study Participants will receive: Study Medications Study related testing Physical exams at no ...

Phase N/A

0.36 miles

Learn More »

Skin Conditions: Must have moderate to severe plaque-type psoriasis. Name of Medication Being Tested: Etanercept (Enbrel ®) Criteria Needed to be Entered into Study: Children 4 to 17 years of age Must have psoriasis for minimum of 6 months Minimum 10% of total body surface area of psoriasis Must have ...

Phase N/A

0.36 miles

Learn More »

Do you experience coughing, wheezing,, shortness of breath and have smoked for years? You may be eligible if you are 40 years of age or older, have a history or diagnosis of COPD and are a current or a smoker in the past.

Phase N/A

0.36 miles

Learn More »

A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis

The purpose of this study is to evaluate the efficacy and safety of baricitinib in adult participants with moderate to severe atopic dermatitis.

Phase

0.36 miles

Learn More »

Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis

This is a multi-center, randomized, double-blind, placebo-controlled study to be conducted in the United States in subjects with atopic dermatitis.

Phase

0.36 miles

Learn More »

A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)

The reason for this study is to see how effective and safe mirikizumab is compared to secukinumab and placebo for moderate to severe plaque psoriasis.

Phase

0.36 miles

Learn More »

A Study to Evaluate the Efficacy Safety and Tolerability of Guselkumab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (HS)

The purpose of this study is to evaluate the efficacy, safety, and tolerability of guselkumab in adult participants with moderate to severe hidradenitis suppurativa (HS).

Phase

0.36 miles

Learn More »